RUGGERI, PIERDOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 504
EU - Europa 349
AS - Asia 147
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 1.006
Nazione #
US - Stati Uniti d'America 502
IE - Irlanda 120
CN - Cina 87
IT - Italia 81
TR - Turchia 41
DE - Germania 34
GB - Regno Unito 29
UA - Ucraina 28
SE - Svezia 24
FI - Finlandia 14
VN - Vietnam 12
CZ - Repubblica Ceca 8
FR - Francia 6
SG - Singapore 6
EU - Europa 4
AU - Australia 2
BE - Belgio 2
CA - Canada 2
IN - India 1
NL - Olanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.006
Città #
Dublin 120
Chandler 114
Jacksonville 111
New York 30
L'aquila 29
Nanjing 26
Wilmington 25
Ashburn 23
Boardman 23
Izmir 20
Beijing 13
Dearborn 12
Dong Ket 12
Lawrence 12
Princeton 12
Ann Arbor 11
Milan 11
San Mateo 11
Nanchang 9
Brno 8
Shenyang 8
Seattle 7
Falls Church 6
Rome 6
Hebei 5
Los Angeles 5
L’Aquila 5
Singapore 5
Tianjin 5
Jiaxing 4
Woodbridge 4
Bologna 3
Catania 3
Dallas 3
Helsinki 3
Jinan 3
Munich 3
Washington 3
Altidona 2
Brussels 2
Changsha 2
Ferentino 2
Hangzhou 2
Kunming 2
Lanciano 2
Mountain View 2
Norwalk 2
Sora 2
Verona 2
Zhengzhou 2
Amsterdam 1
Aversa 1
Berlin 1
Bratislava 1
Canberra 1
Chongqing 1
Cleveland 1
Frosinone 1
Hanover 1
Houston 1
Impruneta 1
Kitzingen 1
Lisbon 1
Montréal 1
Nuremberg 1
Oxford 1
Phoenix 1
Poggio Mirteto 1
Redwood City 1
San Francisco 1
Shanghai 1
Sydney 1
Taiyuan 1
Torano Nuovo 1
Toronto 1
Trieste 1
Wuhan 1
Totale 764
Nome #
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 96
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 95
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 93
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 72
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 68
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 68
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 67
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 66
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 65
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 63
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 61
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 58
null 39
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 38
null 35
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 29
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 27
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 18
Salvianolic Acid B Strikes Back: New Evidence in the Modulation of Expression and Activity of Matrix Metalloproteinase 9 in MDA-MB-231 Human Breast Cancer Cells 4
Totale 1.062
Categoria #
all - tutte 4.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.346


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 14 1 5 21 36 2 16 6 1 14
2020/2021122 1 15 0 15 16 2 15 6 13 4 21 14
2021/202278 8 4 10 3 7 2 3 7 4 4 5 21
2022/2023310 13 28 1 35 26 28 3 12 149 1 6 8
2023/2024120 13 3 14 6 11 41 0 1 0 1 5 25
2024/202524 17 7 0 0 0 0 0 0 0 0 0 0
Totale 1.062